BioPharma Dive Dec 15, 2025 Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease
BioPharma Dive Dec 15, 2025 How rare-disease teams can fine-tune COAs to bridge meaningful change and measurable progress
BioPharma Dive Dec 11, 2025 Biotech venture firm Apple Tree goes bankrupt amid dispute with billionaire backer